Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR)

CUSIP: 92915B106

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
55,632,823
Total 13F shares
35,034,671
Share change
-3,124,984
Total reported value
$205,128,146
Put/Call ratio
87%
Price per share
$5.85
Number of holders
126
Value change
-$20,241,650
Number of buys
54
Number of sells
54

Quarterly Holders Quick Answers

What is CUSIP 92915B106?
CUSIP 92915B106 identifies VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2024

As of 30 Sep 2024, Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,034,671 shares. The largest 10 holders included BlackRock, Inc., ARMISTICE CAPITAL, LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, Erste Asset Management GmbH, GREAT POINT PARTNERS LLC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 126 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.